An open-label, switchover trial to assess the safety and efficacy of agalsidase beta in patients with Fabry disease treated with agalsidase alfa enzyme replacement therapy

Sarah Richards; Dawn Laney; Muhammad A. Pervaiz; Suma Shankar

doi:10.1016/j.ymgme.2013.12.217

An open-label, switchover trial to assess the safety and efficacy of agalsidase beta in patients with Fabry disease treated with agalsidase alfa enzyme replacement therapy

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2013.12.217 ◽

2014 ◽

Vol 111 (2) ◽

pp. S90

Author(s):

Sarah Richards ◽

Dawn Laney ◽

Muhammad A. Pervaiz ◽

Suma Shankar

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Agalsidase Beta ◽

Open Label ◽

Safety And Efficacy ◽

Enzyme Replacement ◽

Agalsidase Alfa

Download Full-text

Safety and Efficacy of Enzyme Replacement Therapy with Agalsidase Beta: An International, Open-label Study in Pediatric Patients with Fabry Disease

The Journal of Pediatrics ◽

10.1016/j.jpeds.2007.09.007 ◽

2008 ◽

Vol 152 (4) ◽

pp. 563-570.e1 ◽

Cited By ~ 94

Author(s):

J. Edmond Wraith ◽

Anna Tylki-Szymanska ◽

Nathalie Guffon ◽

Y. Howard Lien ◽

Michel Tsimaratos ◽

...

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Pediatric Patients ◽

Agalsidase Beta ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Enzyme Replacement

Download Full-text

Successful Management of Enzyme Replacement Therapy in Related Fabry Disease Patients with Severe Adverse Events by Switching from Agalsidase Beta (Fabrazyme®) to Agalsidase Alfa (Replagal®)

10.1007/8904_2014_304 ◽

2014 ◽

Cited By ~ 1

Author(s):

Kazuya Tsuboi ◽

Hiroshi Yamamoto ◽

Fuji Somura ◽

Hiromi Goto

Keyword(s):

Adverse Events ◽

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Agalsidase Beta ◽

Successful Management ◽

Enzyme Replacement ◽

Agalsidase Alfa ◽

Severe Adverse Events

Download Full-text

Enzyme replacement therapy in Fabry disease: Comparison of agalsidase alfa and agalsidase beta

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2008.07.002 ◽

2008 ◽

Vol 95 (1-2) ◽

pp. 114-115 ◽

Cited By ~ 15

Author(s):

Atul Mehta ◽

Michael Beck ◽

Christoph Kampmann ◽

Andrea Frustaci ◽

Dominique P. Germain ◽

...

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Agalsidase Beta ◽

Enzyme Replacement ◽

Agalsidase Alfa

Download Full-text

An open-label clinical trial of agalsidase alfa enzyme replacement therapy in children with Fabry disease who are naïve to enzyme replacement therapy

Drug Design Development and Therapy ◽

10.2147/dddt.s102761 ◽

2016 ◽

pp. 1771 ◽

Cited By ~ 9

Author(s):

Ozlem Goker-Alpan ◽

Nicola Longo ◽

Marie McDonald ◽

Suma Shankar ◽

Raphael Schiffmann ◽

...

Keyword(s):

Clinical Trial ◽

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Open Label ◽

Enzyme Replacement ◽

Agalsidase Alfa

Download Full-text

Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa

Journal of the Chinese Medical Association ◽

10.1016/j.jcma.2013.11.006 ◽

2014 ◽

Vol 77 (4) ◽

pp. 190-197 ◽

Cited By ~ 7

Author(s):

Hsiang-Yu Lin ◽

Yu-Hsiu Huang ◽

Hsuan-Chieh Liao ◽

Hao-Chuan Liu ◽

Ting-Rong Hsu ◽

...

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Agalsidase Beta ◽

Enzyme Replacement ◽

Clinical Observations ◽

Agalsidase Alfa

Download Full-text

Prospective Results of Switching Enzyme Replacement Therapy from Agalsidase beta to Agalsidase alfa in the Canadian Fabry Disease Initiative Study

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2011.11.174 ◽

2012 ◽

Vol 105 (2) ◽

pp. S64-S65

Author(s):

Michael West ◽

Daniel Bichet ◽

Robin Casey ◽

Joe Clarke ◽

Sandra Sirrs ◽

...

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Agalsidase Beta ◽

Enzyme Replacement ◽

Agalsidase Alfa

Download Full-text

An open-label, switchover trial to assess the safety and efficacy of Fabrazyme in patients with Fabry disease treated with Replagal enzyme replacement therapy

Molecular Genetics and Metabolism ◽

10.1016/j.ymgme.2012.11.208 ◽

2013 ◽

Vol 108 (2) ◽

pp. S78-S79

Author(s):

Sarah Richards ◽

Dawn Laney ◽

M. Ali Pervaiz ◽

Suma Shankar

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Open Label ◽

Safety And Efficacy ◽

Enzyme Replacement

Download Full-text

Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease

JIMD Reports - JIMD Reports, Volume 25 ◽

10.1007/8904_2015_483 ◽

2015 ◽

pp. 95-106 ◽

Cited By ~ 10

Author(s):

Ozlem Goker-Alpan ◽

Michael J. Gambello ◽

Gustavo H. B. Maegawa ◽

Khan J. Nedd ◽

Daniel J. Gruskin ◽

...

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Agalsidase Beta ◽

Enzyme Replacement ◽

Agalsidase Alfa

Download Full-text

Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2009.01.007 ◽

2009 ◽

Vol 144 (1) ◽

pp. 92-93 ◽

Cited By ~ 21

Author(s):

G. Kalkum ◽

D. Macchiella ◽

J. Reinke ◽

H. Kölbl ◽

M. Beck

Keyword(s):

Enzyme Replacement Therapy ◽

Pregnant Women ◽

Fabry Disease ◽

Replacement Therapy ◽

Enzyme Replacement ◽

Agalsidase Alfa

Download Full-text

Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease

Biologics: Targets and Therapy ◽

10.2147/btt.s3770 ◽

2008 ◽

pp. 823

Author(s):

David Warnock ◽

Fervenza ◽

Balcells ◽

Linthorst

Keyword(s):

Enzyme Replacement Therapy ◽

Fabry Disease ◽

Replacement Therapy ◽

Safety And Efficacy ◽

Enzyme Replacement

Download Full-text